Executive Change

UNITED STATES SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549     FORM 8-K   CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934     Date of Report (Date of earliest event reported): October 12, 2021     The New York Times Company (Exact name of registrant as specified in its charter)   New York   1-5837   13-1102020 (State or other jurisdiction of incorporation)   (Commission File Number) (I.R.S. Employer Identification No.) 620 Eighth Avenue, New York, New York 10018 (Address and zip code of principal executive offices) Registrant’s telephone number, including area code:  ( 212 ) 556-1234   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock NYT New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) On October 12, 2021, the Board of Directors (the “Board”) of The New York Times Company (the “Company”) appointed Manuel Bronstein to the Board and named him to the Board’s Nominating & Governance Committee. A copy of the Company’s press release, dated October 12, 2021, announcing Mr. Bronstein’s appointment to the Board is attached as Exhibit 99.1 to this Form 8-K and is incorporated by reference herein. Mr. Bronstein will receive the same compensation that is provided from time to time to the Company’s other non-employee directors, including a grant of restricted stock units for the Company’s Class A common stock, with a grant date value of $81,000, representing a prorated amount of the restricted stock units granted to the Company’s non-employee directors on April 28, 2021.      Item 9.01 Financial Statements and Exhibits.   (d)  Exhibits   Exhibit Number Description Exhibit 99.1   The New York Times Company Press Release, dated October 12, 2021 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.    THE NEW YORK TIMES COMPANY       Date: October 12, 2021 By: /s/ Diane Brayton     Diane Brayton     Executive Vice President, General Counsel and Secretary